LPL Financial
ABEO icon

LPL Financial’s Abeona Therapeutics ABEO Stock Holding History

LPL Financial’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$431K Buy
69,795
+4,647
+7% +$25.5K ﹤0.01% 5147
2026
Q1 		$292K Buy
65,148
+2,275
+4% +$11.4K ﹤0.01% 5203
2025
Q4 		$331K Buy
62,873
+3,165
+5% +$15.9K ﹤0.01% 5067
2025
Q3 		$315K Buy
59,708
+710
+1% +$4.5K ﹤0.01% 5013
2025
Q2 		$335K Buy
58,998
+688
+1% +$3.92K ﹤0.01% 4700
2025
Q1 		$278K Buy
58,310
+7,550
+15% +$41.1K ﹤0.01% 4634
2024
Q4 		$283K Sell
50,760
-900
-2% -$5.54K ﹤0.01% 4578
2024
Q3 		$326K Buy
51,660
+675
+1% +$3.52K ﹤0.01% 4358
2024
Q2 		$216K Buy
50,985
+20,445
+67% +$104K ﹤0.01% 4503
2024
Q1 		$221K Buy
30,540
+1,200
+4% +$7.61K ﹤0.01% 4437
2023
Q4 		$147K Buy
29,340
+4,890
+20% +$21.5K ﹤0.01% 4473
2023
Q3 		$103K Buy
+24,450
New +$92.5K ﹤0.01% 4408

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LPL Financial's ABEO Position: Q2 2026 in Review

LPL Financial increased its Abeona Therapeutics (ABEO) stake by 7.1% in Q2 2026, buying an estimated $25.5K and bringing the position to 69,795 shares worth $431K. The position accounts for ﹤0.01% of the portfolio, ranked #5147.

LPL Financial first reported a position in ABEO in Q3 2023 and has held it in 12 quarters since. 126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • LPL Financial held 69,795 shares of Abeona Therapeutics worth $431K as of Q2 2026.
  • LPL Financial bought 4,647 Abeona Therapeutics shares in Q2 2026, an estimated $25.5K.
  • Abeona Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5147 holding.
  • LPL Financial first reported a position in Abeona Therapeutics in Q3 2023 and has held it in 12 quarters since.
  • 126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.